Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.

[1]  Shang-Jyh Hwang,et al.  Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection , 2008, The American Journal of Gastroenterology.

[2]  Ming‐Lung Yu,et al.  Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. , 2008, Journal of hepatology.

[3]  G. Marchesini,et al.  Retinol‐binding protein 4: A new marker of virus‐induced steatosis in patients infected with hepatitis c virus genotype 1 , 2008, Hepatology.

[4]  Ming‐Lung Yu,et al.  Abnormal Liver Function Test Predicts Type 2 Diabetes: a Community-Based Prospective Study , 2008, Diabetes Care.

[5]  G. Rossi,et al.  Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). , 2008, Diabetes Care.

[6]  K. Tsai,et al.  Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan. , 2007, Japanese journal of infectious diseases.

[7]  J. Chan,et al.  Abnormal Liver Function Test Predicts Type 2 Diabetes , 2007, Diabetes Care.

[8]  C. Dai,et al.  Links between triglyceride levels, hepatitis C virus infection and diabetes. , 2007, Gut.

[9]  P. Lepper,et al.  Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease , 2007, Diabetologia.

[10]  Shang-Jyh Hwang,et al.  Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication , 2007, The American Journal of Gastroenterology.

[11]  M. Blüher,et al.  Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects , 2007, Diabetologia.

[12]  R. Simó.  Glucose Abnormalities in Patients With Hepatitis C Virus Infection: Epidemiology and Pathogenesis , 2006, Diabetes Care.

[13]  Arya M. Sharma,et al.  Retinol-Binding Protein 4 in Human Obesity , 2006, Diabetes.

[14]  Jaewon Oh.  Retinol-binding protein 4 and insulin resistance. , 2006, The New England journal of medicine.

[15]  U. Smith,et al.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. , 2006, The New England journal of medicine.

[16]  R. Simó,et al.  Glucose Abnormalities in Patients with Hepatitis C Virus Infection , 2006, Diabetes Care.

[17]  A. Lekkou,et al.  Serum lipid pattern in chronic hepatitis C: histological and virological correlations , 2006, Journal of viral hepatitis.

[18]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[19]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[20]  Nimesh Mody,et al.  Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.

[21]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[22]  R. Andrade,et al.  Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. , 2005, Gastroenterology.

[23]  A. Basu,et al.  Chronic Hepatitis C and Type II Diabetes Mellitus: A Prospective Cross-Sectional Study , 2005, The American Journal of Gastroenterology.

[24]  R. Simó,et al.  High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. , 2004, Diabetes care.

[25]  K. Koike,et al.  Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. , 2004, Gastroenterology.

[26]  Kuninori Shiwaku,et al.  The New BMI Criteria for Asians by the Regional Office for the Western Pacific Region of WHO are Suitable for Screening of Overweight to Prevent Metabolic Syndrome in Elder Japanese Workers , 2003, Journal of occupational health.

[27]  M. Newcomer,et al.  Plasma retinol binding protein: structure and function of the prototypic lipocalin. , 2000, Biochimica et biophysica acta.

[28]  V. Agnello,et al.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Thomssen,et al.  Low density lipoprotein receptor as a candidate receptor for hepatitis C virus , 1999, Journal of medical virology.

[30]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[31]  M. Sakamoto,et al.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. , 1993, The Journal of general virology.

[32]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[33]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[34]  A. Craxì,et al.  751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS , 2008 .

[35]  F. Tacke,et al.  Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. , 2007, Diabetes care.

[36]  B. Pedersen,et al.  Retinol-binding protein 4 and insulin resistance. , 2006, The New England journal of medicine.